Not recruitingISRCTN88882979
HTA Study of Antidepressants for Depression in Dementia: A definitive multi-centre pragmatic randomised controlled double-blind trial of the clinical and cost effectiveness of mirtazapine and sertraline versus placebo for the treatment of depression in dementia presenting in secondary care
Research studyUnited Kingdom
Understand this study
- Listed locations
- United Kingdom
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- King's College London (UK)
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- United Kingdom
- Age range
- Not clearly listed
- Official registry ID
- ISRCTN88882979
- Official title
Show the full official title
HTA Study of Antidepressants for Depression in Dementia: A definitive multi-centre pragmatic randomised controlled double-blind trial of the clinical and cost effectiveness of mirtazapine and sertraline versus placebo for the treatment of depression in dementia presenting in secondary care
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is King's College London (UK), a university.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
Thirty-year follow-up of personality, anxiety and depression after earlier treatment
A before and after study to investigate the effectiveness of an individual psychological intervention in reducing anxiety and depression for heart failure patients
